Blog
New

Trump Administration Announces Plan to Reduce Drug Prices

In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations.

Read More
New

Red Cross Releases Online Course on How to Respond to an Opioid Overdose

The training has information on how to use several products including a nasal atomizer, Narcan Nasal Spray and Evzio.

Read More
New

Nonopioid Lofexidine Safe and Effective for Managing Opioid Withdrawal Syndrome

Lofexidine may expand the treatment options available for managing withdrawal when buprenorphine and methadone are unavailable or undesirable.

Read More
New

Long-term Treatment Outcomes With Aripiprazole Lauroxil in Schizophrenia

Safety, symptoms, and illness trajectory of outpatients with schizophrenia who received ongoing aripiprazole lauroxil were followed for 2 years.

Read More
New

Updates in Borderline Personality Disorder: Your Questions Answered

Borderline personality disorder, a disorder that is often misunderstood by the general public, also raises questions for psychiatrists.

Read More
New

Assessment and Treatment of Depression: A Clinical Look at the Current Controversies

Mark Zimmerman, MD, discusses controversies related to categorizing severity and identifying optimal treatment of depression.

Read More
New

Patients With Schizophrenia Have Difficulty Identifying Auditory Emotion

Patients with schizophrenia have difficulty identifying emotions from the acoustics of a speaker’s voice.

Read More
New

Increased Adherence With Paliperidone Once Every 3 Months in Schizophrenia

Transition from a once-monthly formulation of a long-acting, injectable paliperidone palmitate to a once-every-3-month formulation treatment regimen in patients with schizophrenia demonstrated increased adherence to antipsychotic medication.

Read More
New

Brexpiprazole Appears Safe, Effective in Schizophrenia During Severe Psychotic Episodes

At 6 weeks of treatment, severely ill patients treated with adjunctive brexpiprazole had a greater reduction in PANSS total scores and CGI-S scores compared with those receiving placebo.

Read More
New

In Study of Veterans, Therapy Most Significant Predictor of PTSD Recovery

Patients with PTSD should consider concurrent treatment with evidence-based psychotherapy to maximize their chances for meaningful improvement.

Read More
New

Mortality Rate for Bipolar Disorder Has Increased in Denmark Since the 1990s

Younger individuals may be more at risk for death by suicide, and in older patients, elevated levels of metabolic syndrome may lead to higher rates of death from heart disease.

Read More
New

Schizophrenia Therapy Adherence Tied to Patients’ Beliefs

Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.

Read More
New

Repeated-Dose Ketamine for Reducing Suicidal Ideation in Treatment-Resistant Depression

Investigators sought to examine the short- and long-term antidepressant and antisuicidal effects of repeated-dose ketamine augmentation in patients with treatment-resistant depression.

Read More
New

High Psychopathy Scores Associated With Lower Self-Reported Empathy Levels

The researchers hypothesize that empathy induction activities could increase prosocial behavior among violent offenders.

Read More
New

Long-term Healthy Diet Associated With Greater Hippocampal Volumes

This study presents strong evidence for an association between a healthy diet and hippocampal volumes.

Read More
New

Little to No Association Found Between Physician Performance and Medical School Ranking

Researchers found a limited association between the ranking of a physician’s medical school and patient mortality or readmission rates.

Read More